0001231919-25-000450.txt : 20251110 0001231919-25-000450.hdr.sgml : 20251110 20251107181118 ACCESSION NUMBER: 0001231919-25-000450 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251110 DATE AS OF CHANGE: 20251107 EFFECTIVENESS DATE: 20251110 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001856725 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-563500 FILM NUMBER: 251463854 BUSINESS ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 BUSINESS PHONE: (408) 457-3700 MAIL ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 D 1 primary_doc.xml X0708 D LIVE 0001856725 Rani Therapeutics Holdings, Inc. 2051 RINGWOOD AVENUE SAN JOSE CA CALIFORNIA 95131 (408) 457-3700 CALIFORNIA None None Corporation true 2021 Talat Imran c/o Rani Therapeutics LLC 2051 RINGWOOD AVENUE SAN JOSE CA CALIFORNIA 95131 Executive Officer Director Svai Sanford c/o Rani Therapeutics LLC 2051 RINGWOOD AVENUE San Jose CA CALIFORNIA 95131 Executive Officer Mir Imran c/o Rani Therapeutics LLC 2051 Ringwood Avenue San Jose CA CALIFORNIA 95131 Director Dennis Ausiello c/o rani Therapeutics LLC 2051 Ringwood Avenue San Jose CA CALIFORNIA 95131 Director Jean-Luc Butel c/o Rani Therapeutics LLC 2051 Ringwood Avenue San Jose CA CALIFORNIA 95131 Director Mir Hashim c/o Rani Therapeutics LLC 2051 Ringwood Avenue San Jose CA CALIFORNIA 95131 Executive Officer Lisa Rometty c/o Rani Therapeutics LLC 2051 Ringwood Avenue San Jose CA CALIFORNIA 95131 Director Abraham Bassan c/o Rani Therapeutics LLC 2051 Ringwood Avenue San Jose CA CALIFORNIA 95131 Director Vasudev Bailey, M.D. c/o Rani Therapeutics LLC 2051 Ringwood Avenue San Jose CA CALIFORNIA 95131 Director Biotechnology Decline to Disclose 06b false 2025-10-23 false true true false 0 H.C. Wainwright & Co, LLC 375 None None 430 Park Ave. New York NY NEW YORK 10022 All States true Maxim Group LLC 120708 None None 300 Park Ave. 16th Floor New York NY NEW YORK 10022 All States true 60255052 60255052 0 Includes pre-payment of the aggregate exercise price of $2,870.00 for pre-funded warrants and $6,000,000.00 in debt conversion. false 15 2945625 0 0 false Rani Therapeutics Holdings, Inc. /s/ Svai Sanford Svai Sanford Chief Financial Officer 2025-11-07